Whitener Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Whitener Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,455	Closed	-$273K	–	135
2020 Q3	$273K	Hold	2,455	–	–	0.13%	104
2020 Q2	$274K	Buy	+2,455	New	+$242K	0.14%	107
2020 Q1	–	Sell	-2,650	Closed	-$252K	–	138
2019 Q4	$252K	Buy	2,650 +60	+2%	+$5.19K	0.13%	120
2019 Q3	$197K	Hold	2,590	–	–	0.11%	127
2019 Q2	$227K	Buy	2,590 +400	+18%	+$34.1K	0.13%	119
2019 Q1	$198K	Hold	2,190	–	–	0.13%	120
2018 Q4	$157K	Hold	2,190	–	–	0.12%	128
2018 Q3	$209K	Hold	2,190	–	–	0.14%	121
2018 Q2	$208K	Hold	2,190	–	–	0.16%	119
2018 Q1	$192K	Hold	2,190	–	–	0.15%	119
2017 Q4	$185K	Buy	+2,190	New	+$183K	0.16%	116

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return

Whitener Capital Management's XBI Position: Q4 2020 in Review

Whitener Capital Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2020, closing a stake of 2,455 shares — an estimated $273K sold.

Whitener Capital Management first reported a position in XBI in Q4 2017 and held it in 11 quarters. The position peaked at $274K in Q2 2020. 654 funds tracked by Wall St. Rank hold XBI as of Q4 2020.

Whitener Capital Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2020 after selling out during the quarter.
Whitener Capital Management sold 2,455 State Street SPDR S&P Biotech ETF shares in Q4 2020, an estimated $273K.
Whitener Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2017 and held it in 11 quarters.
Whitener Capital Management's State Street SPDR S&P Biotech ETF position peaked at $274K in Q2 2020.
654 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2020.

Based on Whitener Capital Management's 13F filing for Q4 2020, filed 8 Feb 2021.